Myomo Q2 2024 GAAP EPS $(0.03) Beats $(0.07) Estimate, Sales $7.521M Beat $7.278M Estimate
Portfolio Pulse from Benzinga Newsdesk
Myomo (AMEX:MYO) reported better-than-expected Q2 2024 results with a GAAP EPS of $(0.03), beating the estimate of $(0.07). Sales were $7.521 million, surpassing the $7.278 million estimate and showing a 26.21% increase from the same period last year.
August 06, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Myomo (AMEX:MYO) reported Q2 2024 GAAP EPS of $(0.03), beating the $(0.07) estimate. Sales were $7.521 million, exceeding the $7.278 million estimate and increasing 26.21% YoY.
The better-than-expected earnings and sales figures, along with a significant year-over-year sales increase, are likely to positively impact Myomo's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100